Authors: LATINI R MASSON S JEREMIC G LUVARA G FIORDALISO F CALVILLO L BERNASCONI R TORRI M RONDELLI I RAZZETTI R BONGRANI S

Citation: R. Latini et al., COMPARATIVE EFFICACY OF A DA(2) ALPHA(2) AGONIST AND A BETA-BLOCKER IN REDUCING ADRENERGIC DRIVE AND CARDIAC FIBROSIS IN AN EXPERIMENTAL-MODEL OF LEFT-VENTRICULAR DYSFUNCTION AFTER CORONARY-ARTERY OCCLUSION/, Journal of cardiovascular pharmacology, 31(4), 1998, pp. 601-608

Authors: FORNASIER M PUCCINI P RAZZETTI R ACERBI D BONGRANI S VENTURA P

Citation: M. Fornasier et al., EVALUATION OF POTENTIALLY INJURIOUS EFFECTS OF EXOGENOUS SURFACTANT LYSOPHOSPHOLIPIDS ON THE ALVEOLAR EPITHELIUM AND PULMONARY MECHANICS, Biology of the neonate, 71(5), 1997, pp. 337-344

Authors: CIVELLI M GIOSSI M CARUSO P RAZZETTI R BERGAMASCHI M BONGRANI S GASCO A

Citation: M. Civelli et al., THE INVOLVEMENT OF THE RELEASE OF NITRIC-OXIDE IN THE PHARMACOLOGICALACTIVITY OF THE NEW FUROXAN DERIVATIVE CHF-2363, British Journal of Pharmacology, 118(4), 1996, pp. 923-928

Authors: RAZZETTI R ACERBI D

Citation: R. Razzetti et D. Acerbi, PHARMACOKINETIC AND PHARMACOLOGICAL PROPERTIES OF DELAPRIL, A LIPOPHILIC NONSULFHYDRYL ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR, The American journal of cardiology, 75(16), 1995, pp. 7-12

Authors: CIVELLI M CARUSO P GIOSSI M BERGAMASCHI M RAZZETTI R BONGRANI S GASCO A

Citation: M. Civelli et al., CHF-2206, A NEW POTENT VASODILATING AND ANTIAGGREGATING DRUG AS POTENTIAL NITRIC-OXIDE DONOR, European journal of pharmacology, 255(1-3), 1994, pp. 17-24

Authors: BONGRANI S FORNASIER M PAPOTTI M RAZZETTI R ROBERTSON B

Citation: S. Bongrani et al., LUNG GAS VOLUMES AND EXPIRATORY TIME CONSTANT IN IMMATURE NEWBORN RABBITS TREATED WITH NATURAL OR SYNTHETIC SURFACTANT OR DETERGENTS, Biology of the neonate, 65(6), 1994, pp. 406-415